Press Release

New York, NY ( connect2business.co.uk ) September 23, 2013 - Many patients who want to reduce the appearance of lines and wrinkles turn to some form of injectable filler. Among the number of effective fillers is Dysport, an FDA-approved injection treatment that reduces the appearance of fine lines and wrinkles by relaxing facial muscles. Similar to BOTOX®, Dysport is injected directly into the area of wrinkles to paralyze the underlying muscles and keep them from contracting.

A large advantage that Dysport has over BOTOX is that Dysport can diffuse muscles one to three centimeters from the injection point, while Botox can only reach as far as one centimeter, allowing for results that reach further areas with just a single injection, according to Dr. Sobel.

The Dysport injection treatment was developed in Europe in the early '90s, and has been used effectively ever since. It has also been used in the US under the name Reloxin, but was FDA-approved under its original name, Dysport. In April 2009, Dysport was approved by the FDA for use in the US. The ease of use and effectiveness of Dysport rivals Botox, and it is on its way to becoming one the most popular cosmetic procedure.

Similar to BOTOX, Dysport is made from a protein extracted from the bacterium Clostridium botulinum. This material was originally used to control motor disorders and involuntary muscle spasms by immobilizing the targeted muscles.

One of the reasons that Dr. Sobel's patients love Dysport is that the results are visible within one to seven days after treatment. Most patients see results on day three. With less protein than Botox, Dysport is broken down more slowly by the body, and can provide results that last as long as 13 months.

According to Dr. Sobel aging skin loses its elasticity and the areas where muscles repeatedly contract become permanent lines and wrinkles. This is common on the forehead and around the eyes and mouth. Dysport immobilizes these muscles to restore a youthful and well-rested expression to the face, and actually trains the muscles to contract less often after several treatments.

Dysport injections are ideal for nearly any patient who wishes to reduce the appearance of fine lines and wrinkles on the face and restore a younger and more refreshed appearance.

Dr. Howard Sobel offers Dysport injections in his Manhattan office. Interested parties should contact the Skin & Spa Cosmetic Surgery Center directly at 212-288-0060 or visit Dr. Sobel's website at www.drsobel.com

About Dr. Sobel

Dr. Howard Sobel is a board certified cosmetic dermatologic surgeon currently practicing in New York, NY. He graduated with a degree in medicine from the Albert Einstein School of Medicine, and completed his residency in dermatology and dermatologic surgery at the Emory University School of Medicine. He serves as the editor-in-chief of the International Journal of Cosmetic Surgery and Aesthetic Dermatology, and worked to pioneer the combination of cosmetic surgery with dermatology. For the past thirteen years, he's been recognized by both New York Magazine and the Castle Connolly Guide on How To Find the Best Doctors in the New York, Metropolitan Area as one of New York's best cosmetic dermatologic surgeons, and has appeared on such television programs as the Today Show, Good Morning American, 20/20, and more.

###

Dr. Howard Sobel is a board certified cosmetic dermatologic surgeon currently practicing in New York, NY. He graduated with a degree in medicine from the Albert Einstein School of Medicine, and completed his residency in dermatology and dermatologic surgery at the Emory University School of Medicine.

Organisation Profile:
For the past thirteen years, he’s been recognized by both New York Magazine and the Castle Connolly Guide on How To Find the Best Doctors in the New York, Metropolitan Area as one of New York’s best cosmetic dermatologic surgeons, and has appeared on such television programs as the Today Show, Good Morning American, 20/20, and more. Dr. Sobel can be reached directly at 212-288-4100 or www.DrSobel.com.